Survey of real-world evidence in treatment of patients with CML who desire for bearing children

Survey of real-world evidence in treatment of patients with CML who desire for bearing children - Survey of real-world evidence in treatment of patients with CML who desire for bearing children

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042762

Enrollment

100

Registered

2020-12-15

Start date

2020-12-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Myelogenous Leukemia (CML)

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Female parients with CML, who are/were treated at hematology department in Japan. 2) Diagnosed as chronic-phase CML between 1/1/2002 and 30/11/2020. 3) Diagnosed age was 45 years or younger.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Investigation of real-world evidence for pregnancy in young female patient with CML	—

Secondary

Measure	Time frame
Relation between CML treatment and pregnancy/delivery.	—

Countries

Japan

Contacts

Public ContactTakeshi Kondo

Aiiku Hospital Blood Disorders Center

kondo@aiiku-hp.or.jp+81-11-563-2211

Outcome results